603998 方盛製藥
按盤價 
12.020 +1.090 (+9.973%) | 2024/06 - 中期 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 9.217 | 13.119 | 22.106 | 5.967 | 5.600 |
| 總資產報酬率 ROA (%) | 4.339 | 6.224 | 10.160 | 2.831 | 3.011 |
| 投入資產回報率 ROIC (%) | 5.733 | 8.286 | 14.412 | 4.057 | 3.831 | 邊際利潤分析 |
| 銷售毛利率 (%) | 72.661 | 68.098 | 67.283 | 64.054 | 63.738 |
| 營業利潤率 (%) | 17.006 | 12.063 | 18.529 | 6.362 | 5.660 |
| 息稅前利潤/營業總收入 (%) | 17.467 | 13.150 | 19.336 | 6.921 | 6.465 |
| 淨利潤/營業總收入 (%) | 14.901 | 11.030 | 15.441 | 4.462 | 4.205 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 88.730 | 75.810 | 44.270 | 119.633 | 128.593 |
| 價值變動淨收益/利潤總額(%) | 3.134 | -1.870 | 50.887 | -10.422 | -27.158 |
| 營業外收支淨額/利潤總額(%) | 0.258 | 3.390 | -1.673 | -9.806 | -4.934 | 償債能力分析 |
| 流動比率 (X) | 0.742 | 0.738 | 1.192 | 0.690 | 0.908 |
| 速動比率 (X) | 0.472 | 0.475 | 0.888 | 0.486 | 0.668 |
| 資產負債率 (%) | 49.600 | 48.434 | 48.401 | 51.797 | 43.564 |
| 帶息債務/全部投入資本 (%) | 34.322 | 33.877 | 30.423 | 27.052 | -- |
| 股東權益/帶息債務 (%) | 181.188 | 183.662 | 210.940 | 245.510 | 270.844 |
| 股東權益/負債合計 (%) | 94.429 | 97.710 | 98.279 | 85.381 | 117.880 |
| 利息保障倍數 (X) | 41.893 | 19.796 | 17.386 | 6.143 | 6.034 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 49.264 | 42.791 | 42.267 | 48.957 | 0.000 |
| 存貨周轉天數 (天) | 254.305 | 218.853 | 171.968 | 149.076 | 0.000 |
| 備註： | 即時報價更新時間為 30/09/2024 16:29 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
